Find a list of your saved stories here

Ambu, NeuroSource Medical, and Intronix Technologies collaborate to form advantageous Team Myoguide in Canada


Save Story

Save stories to read later


Estimated read time: 3-4 minutes

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.

[STK]

[IN] HEA MTC MEQ

[SU] LIC PDT

TO BUSINESS, AND MEDICAL EDITORS:

Intronix Technologies Announces New Canadian Distributor for

MyoguideT, the Latest Guided Injection System Innovation

TORONTO, March 5, 2014 /PRNewswire/ -- Leading medical equipment

designer Intronix Technologies (http://www.intronixtech.com) is

pleased to introduce NeuroSource Medical as their new Canadian

distributor for the MyoguideT Needle EMG Guided Injection System.

NeuroSource Medical (http://www.Neuro-Source.com) is a team comprised

of Canadian professionals with over 30 years combined experience. They

not only supply customers with EMG, NCV, IONM, EEG and Sleep

accessories, but also pledge a support system with unparalleled

service, expertise and professionalism. As the new Canadian

distributor for MyoguideT, NeuroSource provides yet another invaluable

service for its customers.

Intronix's breakthrough MyoguideT injection system promises safer,

more effective medication delivery for the treatment of myofascial

pain, spasticity and fibromyalgia. Although MyoguideT is most commonly

utilized with Botox@ and similar drugs, the potential applications for

the system are numerous.

Team Myoguide Canada has also partnered with Ambu

(http://www.ambuusa.com) to provide Ambu's high-quality electrode

sample packs, complimentary with every Myoguide unit purchased from

NeuroSource.

This new partnership presents a unique opportunity of which Canadian

clients will be able to take full advantage. Dr. Evan Friedman,

president of Intronix Technologies, announces, "With Ambu on our

support team, Intronix can now provide our Canadian clinician

customers with samples of Ambu's Neuroline hypodermic needle

electrodes and surface electrode product lines."

The Ambu Inoject Needle administers high-caliber performance at the

top of its class for EMG guided injectable needles. Inoject needles

complement Myoguide injection guidance technology to afford

exceptional results for patients. Ambu's needles secure Botox@ with a

Lure-Lock hub and are compatible with any syringe from 1cc and up. The

Ambu Inoject Needle also delivers complete patient comfort, from the

superior sharpness for skin penetration, to the extreme smoothness for

easy gliding through muscle.

About NeuroSource Medical

With its headquarters located in London Ontario, NeuroSource Medical

is Canada's leading accessory provider of all neurology

EMG/EEG/EP/IONM and Sleep diagnostic testing and monitoring. More than

just a simple distributor, NeuroSource Medical (www.Neuro-Source.com)

has actively participated in the development of most of the products

it sells. Its wealth of neurophysiology expertise provides its

customers with a product backed by experience. This combination of

knowledge and experience has elevated NeuroSource Medical above a

simple distribution model and has served to further strengthen our

relationships with the Canadian Medical Community. For more

information please contact Dr. Brad Watsonbwatson@neuro-source.com, or

visit our website at www.Neuro-Source.com.

About Ambu

Ambu (AMBU-B Copenhagen A/S) develops, produces and markets diagnostic

and life-supporting devices for hospitals and rescue services. Its

most notable products include artificial-respiration ventilation

solutions and single-use electrodes for ECG tests and

neurophysiological mappings. With corporate headquarters in Ballerup,

Denmark and the United States headquarters in Glen Burnie, Md., Ambu

employs approximately 1,700 people worldwide. For more information,

visit www.ambuusa.com or contact Dan Toomey: dct@ambu.com.

About Intronix Technologies Corporation

Located just outside Toronto, Ontario, Intronix Technologies

Corporation designs and produces progressive electromyographic (EMG)

systems for applications in the diagnosis and management of myofascial

pain, spasticity, and fibromyalgia. Its innovations in injection

guidance provide technology that drives clinical solutions to deliver

confidence, improve workflow efficiency, and provide a better patient

experience. Intronix Technologies is known for its exceptional

equipment, plus its comprehensive customer-support programs that are

developed to maximize the lifecycle value of equipment through

responsive service maintenance and significant software support. Learn

more at http://www.intronixtech.com.

Contact:

Dr. Evan Friedman President, Intronix Technologies Corporation

800-819-9996 Email

Read more news from Intronix Technologies Corporation.

SOURCE Intronix Technologies Corporation

-0- 03/05/2014

/Web Site: http://www.intronixtech.com

CO: Intronix Technologies Corporation; NeuroSource Medical; Ambu

ST: Ontario Canada

IN: HEA MTC MEQ

SU: LIC PDT

PRN

-- PH76632 --

0000 03/05/2014 13:30:00 EDT http://www.prnewswire.com

Copyright © The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Most recent Business stories

Related topics

Business
The Associated Press

    SIGN UP FOR THE KSL.COM NEWSLETTER

    Catch up on the top news and features from KSL.com, sent weekly.
    By subscribing, you acknowledge and agree to KSL.com's Terms of Use and Privacy Policy.

    KSL Weather Forecast